Protein Kinases: Potential Drug Targets Against Schistosoma japonicum
Schistosoma japonicum (S. japonicum) infection can induce serious organ damage and cause schistosomiasis japonica which is mainly prevalent in Asia and currently one of the most seriously neglected tropical diseases. Treatment of schistosomiasis largely depends on the drug praziquantel (PZQ). Howeve...
Main Authors: | Kaijuan Wu, Xingyu Zhai, Shuaiqin Huang, Liping Jiang, Zheng Yu, Jing Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.691757/full |
Similar Items
-
Molecular analysis of schistosoma japonicum phosphatidylinositol glycan -- class N gene.
Published: (2004) -
Characterization of cercarial stage-specific antigens of Schistosoma japonicum.
Published: (2005) -
Review Artikel : Perkembangan Vaksin untuk Schistosoma japonicum
by: Anis Nurwidayati
Published: (2017-02-01) -
Characterization of Sj16 in Schistosoma japonicum.
Published: (2005) -
Suppression of Schistosoma japonicum Acetylcholinesterase Affects Parasite Growth and Development
by: Hong You, et al.
Published: (2018-08-01)